Muscle Cramps in Hemodialysis Patients: A Randomized Controlled Trial
NCT ID: NCT06866470
Last Updated: 2025-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-04-05
2025-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This randomized controlled trial aims to evaluate the effects of massage and progressive muscle relaxation exercises on the frequency and severity of muscle cramps in hemodialysis patients. The findings are expected to contribute to evidence-based practices in symptom management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Joint Mobilization in the Treatment of Chronic Ankle Instability
NCT01438905
Effects of Roller Massage on Short-Term Passive Muscle Stiffness
NCT04571034
Chiropractic and Exercise for Seniors With Neck Pain
NCT00269308
Massage on Pain Levels, Range of Motion, and Muscle Strength in Unilateral Lower Limb Amputees
NCT03389334
Mechanisms Underlying Local and Systemic Effects of Massage
NCT04131712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population and Sample The study population consists of all hemodialysis patients registered at the study center, while the sample will include voluntary hemodialysis patients with similar demographic characteristics and dialysis treatment methods who meet the study criteria. Since no identical study exists in the literature, a power analysis was conducted to determine the sample size required to show a significant difference in the reduction of the mean number of cramps (effect size = 1), with 80% power and a 5% Type I error rate. Accordingly, 30 patients per group (massage group, PMRE group, and control group), totaling 90 patients, were planned for inclusion in the study.
Inclusion criteria:
Aged 18 years and older Receiving chronic hemodialysis treatment Experiencing muscle cramps in the last three months No physical or mental health conditions preventing communication
Exclusion criteria:
Presence of acute health issues requiring additional pharmacological treatment Inability to complete PMRE or massage applications Randomization Patients who meet the inclusion criteria and provide consent will undergo an initial interview conducted by the primary researcher, during which baseline data will be collected. Patients will be stratified based on dialysis session frequency, cramp frequency, age, and gender. To ensure homogeneity, patients will be asked about the frequency and severity of cramps experienced in the previous week. Based on the mean cramp frequency and severity scores obtained, hemodialysis patients will be categorized accordingly. Group assignments will be determined using simple randomization via an online tool (www.randomizer.org).
Data Collection Tools Demographic Information Form: Designed to collect participants' demographic and clinical characteristics.
Muscle Cramp Severity and Frequency Scale: This tool will assess the frequency and severity of muscle cramps. Developed based on a literature review, the scale records the date and frequency of cramps. Cramp episodes are defined according to the literature as involuntary leg movements lasting longer than one minute in hemodialysis patients. The number of episodes experienced during each dialysis session will be recorded.
Renal Function Tests: Parameters such as serum creatinine and urea levels will be evaluated.
Chronometer: A calibrated chronometer will be used to measure cramp duration, recorded in minutes.
Interventions Foot Massage Application: Participants will receive a 20-minute foot massage. The massage will be applied during dialysis treatment using techniques that support circulation to enhance tissue oxygenation and remove metabolic waste.
Foot Massage Protocol Before starting, the feet will be evaluated. Then, the feet will be cleaned with a wet compress and dried before proceeding with the massage. The total duration will be 20 minutes, with 10 minutes per foot. The massage will include five manipulation techniques: effleurage, petrissage, friction, percussion, and vibration, with only effleurage, petrissage, and friction used in this study.
Effleurage (Stroking): A light stroking movement over the skin. The massage starts and ends with effleurage, applying minimal pressure with the whole palm in a slow and steady motion using one or both hands. The fingers, except the thumbs, remain close together. Effleurage lasts approximately 2 minutes.
Petrissage (Kneading): The foot is kneaded by compressing and releasing it with both hands. This technique lasts around 3 minutes.
Friction: Circular and elliptical pressing and gliding movements are applied with the fingertips, from the sole to the dorsum of the foot, using varying pressures. This technique is performed for 5 minutes using the fingertips of the index or middle finger. The movement progresses towards the heart in small circular motions while applying adequate pressure.
Progressive Muscle Relaxation Exercises (PMRE): A 20-minute PMRE session will be conducted by the researcher. Participants will systematically tense and relax muscle groups throughout their bodies while undergoing dialysis treatment.
Progressive Muscle Relaxation Protocol
Before starting, participants will be given detailed information about the process. The exercises will focus on major muscle groups and follow these steps:
Foot Muscles: The foot muscles will be tensed for 5 seconds and then relaxed. Leg Muscles: The calf and thigh muscles will be stretched and relaxed in various positions.
Arm and Shoulder Muscles: The arms will be stretched forward and sideways, relaxing the muscles with active and passive relaxation movements.
Face and Neck Muscles: The forehead, jaw, and neck muscles will be tensed and then relaxed.
Duration and Repetitions: Each movement will involve 5-10 seconds of tension and 10-15 seconds of relaxation, with the entire protocol lasting approximately 20 minutes.
Completion: The session will conclude with deep breathing and relaxation exercises.
Both interventions will be applied twice a week for three weeks.
Control Group Participants in the control group will receive only routine hemodialysis treatment. They will not be exposed to any additional interventions during the data collection process.
Data Collection and Evaluation Study data will be collected at two time points: before the intervention (Day 1) and after the intervention (at the end of the 3rd week). The severity and frequency of muscle cramps will be assessed using the demographic information form and muscle cramp assessment scale. Blood tests will be conducted to measure serum creatinine and urea levels.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
stretching exercise group
stretching exercise group
relaxation group
exercise group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
relaxation group
exercise group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
History of Muscle Cramps: Patients who have experienced muscle cramps at least twice a week in the past month.
Age Range: Between 18 and 75 years old. Must be able to swallow tablets Cognitive and Physical Suitability: Having the cognitive and physical capacity to understand and perform massage and progressive muscle relaxation exercises.
Stable Cardiovascular Condition: No history of myocardial infarction or severe cardiovascular complications in the past three months.
Stable Medical Condition: No acute or severe medical conditions other than dialysis treatment.
Voluntary Participation: Signing the informed consent form after being fully informed about the study.
Exclusion Criteria
* Neuromuscular Disorders: Presence of conditions such as multiple sclerosis, Parkinson's disease, or peripheral neuropathy.
Severe Cardiovascular Diseases: History of myocardial infarction, congestive heart failure (NYHA class III-IV), or uncontrolled hypertension in the past three months.
Severe Orthopedic or Rheumatic Conditions: Severe osteoarthritis, rheumatoid arthritis, or other chronic musculoskeletal disorders.
Acute Infections or Inflammatory Conditions: Diagnosis of an active infection or inflammatory disease during the study period.
Mental or Psychiatric Disorders: Presence of severe cognitive impairment, dementia, or major depression/anxiety.
End-Stage Cancer Diagnosis: Undergoing active cancer treatment or having metastatic cancer.
Contraindications to Massage or Relaxation Exercises: Presence of skin infections, open wounds, or any medical condition preventing massage or exercise application.
Regular Use of Alternative Therapies: Engaging in regular massage therapy, yoga, or similar relaxation techniques within the past three months.
Pregnancy: Being pregnant or in the breastfeeding period. Inability to Comply with the Study: Difficulty in attending the study regularly or adhering to the assigned interventions.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Yalova
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
gürcan solmaz
Role: STUDY_DIRECTOR
Istanbul University - Cerrahpasa
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tXazkY4r
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.